Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of the Rheumatic Diseases

Topics

Medicine

Immunology

Pathology

Internal Medicine

Hematology

Show all topics

DOI

10.1136/ard.2008.099010

License

CC-BY-NC

Other Formats

PDF